Export 90 results:
Author Title [ Type(Desc)] Year
Filters: Author is Cruz, F.  [Clear All Filters]
Journal Article
Athanasopoulos, A., & Cruz, F. (2011). The medical treatment of overactive bladder, including current and future treatments. Expert Opinion on Pharmacotherapy, 12(7), 1041 - 1055.
Ferreira, S. G., Lomaglio, T., Avelino, A., Cruz, F., et al. (2009). N-acyldopamines control striatal input terminals via novel ligand-gated cation channels. Neuropharmacology, 56(3), 676 - 683.
Baiou, D., Santha, P., Avelino, A., Charrua, A., et al. (2007). Neurochemical characterization of insulin receptor-expressing primary sensory neurons in wild-type and vanilloid type 1 transient receptor potential receptor knockout mice. Journal of Comparative Neurology, 503(2), 334 - 347.
Cruz, F., & Desgrandchamps, F. (2010). New Concepts and Pathophysiology of Lower Urinary Tract Symptoms in Men. European Urology, Supplements, 9(4), 472 - 476.
Dickson, A., Avelino, A., Cruz, F., & Ribeiro-da-Silva, A. (2006). Peptidergic sensory and parasympathetic fiber sprouting in the mucosa of the rat urinary bladder in a chronic model of cyclophosphamide-induced cystitis. Neuroscience, 139(2), 671 - 685.
Dickson, A., Avelino, A., Cruz, F., & Ribeiro-da-Silva, A. (2006). Peptidergic sensory and parasympathetic fiber sprouting in the mucosa of the rat urinary bladder in a chronic model of cyclophosphamide-induced cystitis (DOI:10.1016/j.neuroscience.2005.11.050). Neuroscience, 141(3), 1633 - 1647.
Pinto, R., Lopes, T., Silva, J., Silva, C., et al. (2013). Persistent therapeutic effect of repeated injections of onabotulinum toxin A in refractory bladder pain syndrome/interstitial cystitis. Journal of Urology, 189(2), 548 - 553.
Andersson, K. - E., Chapple, C. R., Cardozo, L., Cruz, F., et al. (2009). Pharmacological treatment of overactive bladder: Report from the International Consultation on Incontinence. Current Opinion in Urology, 19(4), 380 - 394.
Santos-Silva, A., Charrua, A., Cruz, C. D., Gharat, L., et al. (2012). Rat detrusor overactivity induced by chronic spinalization can be abolished by a transient receptor potential vanilloid 1 (TRPV1) antagonist. Autonomic Neuroscience: Basic and Clinical, 166(1-2), 35 - 38.
Cruz, F. (2016). Re: Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE). European Urology, 70(5), 892.
Oliveira, R., Botelho, F., Silva, P., Resende, A., et al. (2011). Reply from authors re: Elisabetta costantini and massimo lazzeri. Surgery for stress urinary incontinence: So near and yet so far. Eur Urol 2011;59:945-6. European Urology, 59(6), 947.
Coelho, A., Cruz, F., Cruz, C. D., & Avelino, A. (2012). Reply from Authors re: Prokar Dasgupta. Volume matters: Bladder injections of botulinum toxin type A. Eur Urol 2012;61:1185-6: Yes, Volume matters: Bladder injections of botulinum toxin type A. European Urology, 61(6), 1186 - 1187.
Cruz, F., Silva, J., Pinto, R., Carvallho, T., et al. (2009). Reply to Tomasz Drewa, Zbigniew Wolski and Janusz Tyloch's Letter to the Editor re: João Silva, Rui Pinto, Tiago Carvallho, et al. Mechanisms of Prostate Atrophy after Glandular Botulinum Neurotoxin Type A Injection: An Experimental Study in the Rat. Eur. European Urology, 56(5), e28 - e29.
Cruz, F., & Dinis, P. (2007). Resiniferatoxin and botulinum toxin type A for treatment of lower urinary tract symptoms. Neurourology and Urodynamics, 26(6 SUPPL.), 920 - 927.
Frias, B., Santos, J., Morgado, M., Sousa, M. M., et al. (2015). The role of brain-derived neurotrophic factor (BDNF) in the development of neurogenic detrusor overactivity (NDO). Journal of Neuroscience, 35(5), 2146 - 2160.
Pinto, R., Frias, B., Allen, S., Dawbarn, D., et al. (2010). Sequestration of brain derived nerve factor by intravenous delivery of TrkB-Ig2 reduces bladder overactivity and noxious input in animals with chronic cystitis. Neuroscience, 166(3), 907 - 916.
Oliveira, R., Silva, A., Pinto, R., Silva, J., et al. (2009). Short-term assessment of a tension-free vaginal tape for treating female stress urinary incontinence. BJU International, 104(2), 225 - 228.
Oliveira, R., Botelho, F., Silva, P., Resende, A., et al. (2011). Single-incision sling system as primary treatment of female stress urinary incontinence: Prospective 12 months data from a single institution. BJU International, 108(10), 1616 - 1621.
Cruz, C. D., & Cruz, F. (2011). Spinal cord injury and bladder dysfunction: New ideas about an old problem. TheScientificWorldJournal, 11, 214 - 234.
Cruz, C. D., McMahon, S. B., & Cruz, F. (2006). Spinal ERK activation contributes to the regulation of bladder function in spinal cord injured rats. Experimental Neurology, 200(1), 66 - 73.
Coelho, A., Cruz, F., Cruz, C. D., & Avelino, A. (2012). Spread of onabotulinumtoxinA after bladder injection. Experimental study using the distribution of cleaved SNAP-25 as the marker of the toxin action. European Urology, 61(6), 1178 - 1184.
Oliveira, R., Silva, C., Dinis, P., & Cruz, F. (2011). Suburethral single incision slings in the treatment of female stress urinary incontinence: What is the evidence for using them in 2010?. Archivos Espanoles de Urologia, 64(4), 339 - 346.
Bunn, F., Kirby, M., Pinkney, E., Cardozo, L., et al. (2015). Is there a link between overactive bladder and the metabolic syndrome in women? A systematic review of observational studies. International Journal of Clinical Practice, 69(2), 199 - 217.
Avelino, A., Charrua, A., Frias, B., Cruz, C., et al. (2013). Transient receptor potential channels in bladder function. Acta Physiologica, 207(1), 110 - 122.
Charrua, A., Cruz, C. D., Cruz, F., & Avelino, A. (2007). Transient Receptor Potential Vanilloid Subfamily 1 is Essential for the Generation of Noxious Bladder Input and Bladder Overactivity in Cystitis. Journal of Urology, 177(4), 1537 - 1541.

Pages


Home | Site Map | Contacts | Credits | Privacy & Cookies | Intranet | Social Networks |


rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 220 408 800 | email: info@ibmc.up.pt | © copyright 2010 ibmc